TRIPT-OH

Welcome to the Brand page for “TRIPT-OH”, which is offered here for Pharmaceuticals preparations for the treatment of psychogenic depression, endogenous depression, involutional depression, epilepsy, parkinson's disease, myoclonia, choreic movements, down's syndrome, phenylketonuria, migraine and vasomotor cephalalgia, sleep disorders, central nervous system disorders and dietary supplements containing tripytophane;.

Its status is currently believed to be active. Its class is unavailable. “TRIPT-OH” is believed to be currently owned by “SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.”